Acta Anaesthesiologica Scandinavica · 2000 · 17 citations · 11 references
MedicinePharmacologyClinical PharmacologyExperimental PharmacologyPharmacodynamicsAsthma ManagementAsthma PharmacotherapyBronchodilator TherapyCholinergic PharmacologyAirway Smooth Muscle PhysiologyAsthma Bronchodilator TherapyMuscle Relaxant EffectsPhosphodiesterase InhibitionPhosphodiesterase SignalingPositive Inotropic AgentsSmooth Muscle Contraction
We investigated the effect of amrinone, a phosphodiesterase III inhibitor, on rat airway smooth muscle, and thereafter, compared its activity with aminophylline and diltiazem. Amrinone produced relaxation of the acetylcholine-induced airway contraction in a dose-related manner. This bronchodilatory activity of amrinone was similar to that of aminophylline, but smaller than that of diltiazem. The 50% relaxant effect (ED50) of amrinone, aminophylline and diltiazem were 3.6 x 10(-4) M, 1.4 x 10(-4) M and 1.4 x 10(-5) M, respectively. Diltiazem was the most potent airway relaxant, and amrinone was less potent in these experiments. Taken together in its positive inotropic and chronotropic effects and anti-inflammatory activity, however, amrinone could be beneficial for treatment of patients suffering from asthma or heart failure with cardiac asthma.
11
Paul J. Silver, L T Hamel, Mark H. Perrone et al. · European Journal of Pharmacology · 1988 · 109 citations
Mohammed Shahid, Ronald G.M. van Amsterdam, J. de Boer et al. · British Journal of Pharmacology · 1991 · 89 citations · Full text
Nifedipine in the prevention of asthma induced by exercise and histamine.
PA Corris, S Nariman, Gretchen Gibson · PubMed · 1983 · 65 citations